Dice therapeutics share price
WebRecommended price was used for launch, segmentation drove sales strategy, and the forecast informed supply planning, sales compensation … WebDice Therapeutics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Your browser of choice has not been tested …
Dice therapeutics share price
Did you know?
WebApr 10, 2024 · According to 15 analysts, the average rating for DICE stock is "Buy." The 12-month stock price forecast is $63.97, which is an increase of 138.43% from the latest price. WebFind the latest DICE Therapeutics, Inc. (DICE) stock quote, history, news and other vital information to help you with your stock trading and investing. Discover historical prices for DICE stock on Yahoo Finance. View daily, weekly or … Find the latest DICE Therapeutics, Inc. (DICE) stock discussion in Yahoo … DICE Therapeutics, Inc. (DICE) NasdaqGM - NasdaqGM Real Time Price. Currency … Find out all the key statistics for DICE Therapeutics, Inc. (DICE), including … Holder Shares Date Reported % Out Value; Price (T.Rowe) New Horizons Fund: … Get the detailed quarterly/annual income statement for DICE Therapeutics, Inc. … Interactive Chart for DICE Therapeutics, Inc. (DICE), analyze all the data with a … See DICE Therapeutics, Inc. (DICE) stock analyst estimates, including earnings … DICE Therapeutics, Inc. 400 East Jamie Court Suite 300 South San Francisco, … See DICE Therapeutics, Inc. (DICE) Environment, Social and Governance …
WebDice Therapeutics has raised a total of $532.4M in funding over 7 rounds. Their latest funding was raised on Oct 17, 2024 from a Post-IPO Equity round. ... IPO Share Price $17.00; IPO Date Sep 14, 2024; Stock chart by . Investors. Edit Investors Section. Number of Lead Investors 4. WebApr 6, 2024 · The Dice Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd …
WebApr 2, 2024 · The company has a market cap of $1.37 billion, a price-to-earnings ratio of -13.39 and a beta of 0.71. DICE Therapeutics has a 1-year low of $12.64 and a 1-year high of $45.99. The company’s ... WebThe DICE Therapeutics 52-week high stock price is 45.99, which is 71.4% above the current share price. The DICE Therapeutics 52-week low stock price is 12.63, which is …
WebStock analysis for DICE Therapeutics Inc (DICE:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
WebGet the latest Dice Therapeutics Inc (DICE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. in case of adversityWebApr 8, 2024 · What is DICE Therapeutics' stock price forecast for 2024? 8 Wall Street research analysts have issued 12 month price targets for DICE Therapeutics' shares. … in case of accident info sheetWebMar 3, 2024 · About DICE Therapeutics, Inc. 279 EAST GRAND AVENUE SUITE 300, LOBBY B, SOUTH SAN FRANCISCO, California, 94080, United States +1 650 566-1420 … in case of all cereals pulses and oil seedsWeb19 hours ago · Price To Cash Flow is a widely used stock evaluation measure. Find the latest Price To Cash Flow for DICE Therapeutics (DICE) ... or P/CF is price divided by … in case of amensalismWebSep 15, 2024 · DICE Therapeutics (DICE) has priced its upsized IPO of 12M shares of common stock at $17.00/share, for expected gross proceeds of $204M.The company … in case of accident formdvd south africaWebWe design and develop innovative oral medicines against biologically validated targets in immunology for the treatment of chronic autoimmune and inflammatory diseases. We are … in case of an investigation copypasta